179 related articles for article (PubMed ID: 29435118)
1. Assessment of folate receptor alpha and beta expression in selection of lung and pancreatic cancer patients for receptor targeted therapies.
Shen J; Hu Y; Putt KS; Singhal S; Han H; Visscher DW; Murphy LM; Low PS
Oncotarget; 2018 Jan; 9(4):4485-4495. PubMed ID: 29435118
[TBL] [Abstract][Full Text] [Related]
2. Assessment of folate receptor-β expression in human neoplastic tissues.
Shen J; Putt KS; Visscher DW; Murphy L; Cohen C; Singhal S; Sandusky G; Feng Y; Dimitrov DS; Low PS
Oncotarget; 2015 Jun; 6(16):14700-9. PubMed ID: 25909292
[TBL] [Abstract][Full Text] [Related]
3. The folate receptor as a rational therapeutic target for personalized cancer treatment.
Assaraf YG; Leamon CP; Reddy JA
Drug Resist Updat; 2014; 17(4-6):89-95. PubMed ID: 25457975
[TBL] [Abstract][Full Text] [Related]
4. A folate receptor-α-specific ligand that targets cancer tissue and not sites of inflammation.
Vaitilingam B; Chelvam V; Kularatne SA; Poh S; Ayala-Lopez W; Low PS
J Nucl Med; 2012 Jul; 53(7):1127-34. PubMed ID: 22693311
[TBL] [Abstract][Full Text] [Related]
5. Expression of functional folate receptors in multiple myeloma.
Zhou Y; Unno K; Hyjek E; Liu H; Zimmerman T; Karmakar S; Putt KS; Shen J; Low PS; Wickrema A
Leuk Lymphoma; 2018 Dec; 59(12):2982-2989. PubMed ID: 29616859
[TBL] [Abstract][Full Text] [Related]
6. Tumor detection using folate receptor-targeted imaging agents.
Sega EI; Low PS
Cancer Metastasis Rev; 2008 Dec; 27(4):655-64. PubMed ID: 18523731
[TBL] [Abstract][Full Text] [Related]
7. Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments.
Ledermann JA; Canevari S; Thigpen T
Ann Oncol; 2015 Oct; 26(10):2034-43. PubMed ID: 26063635
[TBL] [Abstract][Full Text] [Related]
8. Folate Receptor-Beta Has Limited Value for Fluorescent Imaging in Ovarian, Breast and Colorectal Cancer.
de Boer E; Crane LM; van Oosten M; van der Vegt B; van der Sluis T; Kooijman P; Low PS; van der Zee AG; Arts HJ; van Dam GM; Bart J
PLoS One; 2015; 10(8):e0135012. PubMed ID: 26248049
[TBL] [Abstract][Full Text] [Related]
9. Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung: potential target for folate-linked therapeutic agents.
Cagle PT; Zhai QJ; Murphy L; Low PS
Arch Pathol Lab Med; 2013 Feb; 137(2):241-4. PubMed ID: 22984810
[TBL] [Abstract][Full Text] [Related]
10. Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors.
Fisher RE; Siegel BA; Edell SL; Oyesiku NM; Morgenstern DE; Messmann RA; Amato RJ
J Nucl Med; 2008 Jun; 49(6):899-906. PubMed ID: 18483093
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
[TBL] [Abstract][Full Text] [Related]
12. Targeting folate receptors to treat invasive urinary bladder cancer.
Dhawan D; Ramos-Vara JA; Naughton JF; Cheng L; Low PS; Rothenbuhler R; Leamon CP; Parker N; Klein PJ; Vlahov IR; Reddy JA; Koch M; Murphy L; Fourez LM; Stewart JC; Knapp DW
Cancer Res; 2013 Jan; 73(2):875-84. PubMed ID: 23204225
[TBL] [Abstract][Full Text] [Related]
13. Effect of receptor occupancy on folate receptor internalization.
Bandara NA; Hansen MJ; Low PS
Mol Pharm; 2014 Mar; 11(3):1007-13. PubMed ID: 24446917
[TBL] [Abstract][Full Text] [Related]
14. Enhancing tumor response to targeted chemotherapy through up-regulation of folate receptor α expression induced by dexamethasone and valproic acid.
Péraudeau E; Cronier L; Monvoisin A; Poinot P; Mergault C; Guilhot F; Tranoy-Opalinski I; Renoux B; Papot S; Clarhaut J
J Control Release; 2018 Jan; 269():36-44. PubMed ID: 29129656
[TBL] [Abstract][Full Text] [Related]
15. Folate receptor expression on murine and human adipose tissue macrophages.
Hansen MJ; Achini Bandara N; Low PS
Inflamm Res; 2015 Sep; 64(9):697-706. PubMed ID: 26149693
[TBL] [Abstract][Full Text] [Related]
16. Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133.
Meier R; Henning TD; Boddington S; Tavri S; Arora S; Piontek G; Rudelius M; Corot C; Daldrup-Link HE
Radiology; 2010 May; 255(2):527-35. PubMed ID: 20413763
[TBL] [Abstract][Full Text] [Related]
17. Imaging the folate receptor on cancer cells with 99mTc-etarfolatide: properties, clinical use, and future potential of folate receptor imaging.
Maurer AH; Elsinga P; Fanti S; Nguyen B; Oyen WJ; Weber WA
J Nucl Med; 2014 May; 55(5):701-4. PubMed ID: 24732155
[TBL] [Abstract][Full Text] [Related]
18. Targeted folate receptor β fluorescence imaging as a measure of inflammation to estimate vulnerability within human atherosclerotic carotid plaque.
Jager NA; Westra J; van Dam GM; Teteloshvili N; Tio RA; Breek JC; Slart RH; Boersma H; Low PS; Bijl M; Zeebregts CJ
J Nucl Med; 2012 Aug; 53(8):1222-9. PubMed ID: 22855837
[TBL] [Abstract][Full Text] [Related]
19. Folate Receptor-Targeted Diagnostics and Therapeutics for Inflammatory Diseases.
Yi YS
Immune Netw; 2016 Dec; 16(6):337-343. PubMed ID: 28035209
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of folate derived PET imaging agents with [(18)F]-2-fluoro-2-deoxy-d-glucose using a rodent inflammatory paw model.
Kularatne SA; Bélanger MJ; Meng X; Connolly BM; Vanko A; Suresch DL; Guenther I; Wang S; Low PS; McQuade P; Trotter DG
Mol Pharm; 2013 Aug; 10(8):3103-11. PubMed ID: 23819524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
